Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results
Go back to Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.57 +0.03 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.54 | 52 Week High | $1.11 | |||
| Open | $2.55 | 52 Week Low | $0.41 | |||
| Day High | $2.61 | P/E | N/A | |||
| Day Low | $2.53 | EPS | $-0.29 | |||
| Volume | 747,635 | |||||
